Page last updated: 2024-09-04

torcetrapib and gw 590735

torcetrapib has been researched along with gw 590735 in 1 studies

Compound Research Comparison

Studies
(torcetrapib)
Trials
(torcetrapib)
Recent Studies (post-2010)
(torcetrapib)
Studies
(gw 590735)
Trials
(gw 590735)
Recent Studies (post-2010) (gw 590735)
27328831105

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barone, FC; Brusq, JM; Grillot, DA; Hansen, MK; Issandou, M; Legos, JJ; McVey, MJ; White, RF1

Other Studies

1 other study(ies) available for torcetrapib and gw 590735

ArticleYear
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
    Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:2

    Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Fenofibrate; Humans; Mice; Mice, Transgenic; PPAR alpha; Propionates; Quinolines; Thiazoles

2010